GSK plc reported that on October 29, 2025, two executives sold shares: Regis Simard sold 37,000 shares at £16.8395 each, and Deborah Waterhouse sold 120,000 shares at £16.8865 each. This filing falls under the category of Changes in management or control, with a neutral sentiment and significant implications for investors.